Atrium Therapeutics, Inc. Common StockRNA

Atrium Therapeutics, Inc. is a biopharmaceutical company focused on pioneering the delivery of RNA-based therapeutics specifically to the heart to potentially transform how cardiomyopathies and other cardiovascular diseases are treated. The company's core technology builds on a targeted RNA delivery platform that combines the tissue targeting capabilities of monoclonal antibodies and other ligands with the precision of oligonucleotides, enabling selective delivery of small interfering RNA (siRNA) to cardiac tissues - an approach designed to address underlying genetic contributors to disease that were previously difficult to.

atriumtherapeutics.com